Jasper Therapeutics, Inc. (JSPR)
0.6932
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 13:40
Jasper Therapeutics Price to Book Value : 13.78 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 14.10 |
| September 04, 2026 | 14.08 |
| September 03, 2026 | 13.64 |
| September 02, 2026 | 14.01 |
| September 01, 2026 | 13.86 |
| August 31, 2026 | 14.14 |
| August 28, 2026 | 13.90 |
| August 27, 2026 | 13.89 |
| August 26, 2026 | 14.27 |
| August 25, 2026 | 14.31 |
| August 24, 2026 | 14.36 |
| August 21, 2026 | 14.23 |
| August 20, 2026 | 13.74 |
| August 19, 2026 | 14.84 |
| August 18, 2026 | 14.90 |
| August 17, 2026 | 16.74 |
| August 14, 2026 | 15.70 |
| August 13, 2026 | 17.15 |
| August 12, 2026 | 16.37 |
| August 11, 2026 | 17.75 |
| August 10, 2026 | 15.89 |
| August 07, 2026 | 14.10 |
| August 06, 2026 | 12.84 |
| August 05, 2026 | 13.11 |
| August 04, 2026 | 13.22 |
| Date | Value |
|---|---|
| August 03, 2026 | 12.05 |
| July 31, 2026 | 12.52 |
| July 30, 2026 | 12.34 |
| July 29, 2026 | 11.93 |
| July 28, 2026 | 12.58 |
| July 27, 2026 | 13.80 |
| July 24, 2026 | 13.68 |
| July 23, 2026 | 14.49 |
| July 22, 2026 | 14.80 |
| July 21, 2026 | 15.30 |
| July 20, 2026 | 16.18 |
| July 17, 2026 | 17.59 |
| July 16, 2026 | 15.38 |
| July 15, 2026 | 13.75 |
| July 14, 2026 | 14.36 |
| July 13, 2026 | 12.08 |
| July 10, 2026 | 11.52 |
| July 09, 2026 | 11.55 |
| July 08, 2026 | 10.23 |
| July 07, 2026 | 9.572 |
| July 06, 2026 | 9.260 |
| July 02, 2026 | 8.511 |
| July 01, 2026 | 9.032 |
| June 30, 2026 | 8.366 |
| June 29, 2026 | 3.457 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.04 |
| Anika Therapeutics, Inc. | 2.036 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.715 |
Price to Book Value Related Metrics
| Price | 0.6932 |
| Earnings Yield | -228.1% |
| Market Cap | 19.46M |